OXYGENTA PHARMACEUTICAL
|
The Current P/S Ratio of OXYGENTA PHARMACEUTICAL is 1.77.
| Share Price | ₹53.6 | Jan 02,2026 |
| Market Cap | ₹198.1 Cr | |
| Sales-TTM | ₹112.1 Cr | TTM-Standalone Results |
| Price/Sales | 1.77x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of OXYGENTA PHARMACEUTICAL
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹198.1 Cr] as on Jan 02,2026
(/) Sales [ ₹112.1 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 1.77x ]
Thus, for OXYGENTA PHARMACEUTICAL , the investors are currently willing to pay '1.77 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of OXYGENTA PHARMACEUTICAL !
The chart below summarizes the trend in P/S Ratio of OXYGENTA PHARMACEUTICAL over the last five years.
Historical PS (Price/Sales) ratio chart of OXYGENTA PHARMACEUTICAL
PS Ratio Performance Analysis for OXYGENTA PHARMACEUTICAL
- OXYGENTA PHARMACEUTICAL 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.48x.
- OXYGENTA PHARMACEUTICAL 's operated at median p/e ratio of 1.68x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, OXYGENTA PHARMACEUTICAL 's p/e ratio peaked in Mar2025 at 2.69x.
- OXYGENTA PHARMACEUTICAL 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does OXYGENTA PHARMACEUTICAL 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| OXYGENTA PHARMACEUTICAL | 112.1 | 1.77 | 198.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.55 | 414,929.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 16.92 | 169,644.0 |
| CIPLA LTD | 28,349.6 | 4.31 | 122,050.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.73 | 131,481.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.05 | 104,784.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.70 | 90,922.4 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.77 | 92,221.4 |
| LUPIN LTD | 24,750.7 | 3.89 | 96,195.0 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.17 | 70,547.1 |
| ABBOTT INDIA LTD | 6,714.4 | 8.89 | 59,713.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs OXYGENTA PHARMACEUTICAL 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.77x |
| Max industry PS | 16.92x |
| Median industry PS | 4.31x |
| Average industry PS | 6.34x |
You may also like the below Video Courses